Literature DB >> 3286672

Urinary growth hormone (GH) measurements are useful for evaluating endogenous GH secretion.

I Sukegawa1, N Hizuka, K Takano, K Asakawa, R Horikawa, S Hashida, E Ishikawa, Z Mohri, Y Murakami, K Shizume.   

Abstract

Daily (24-h) urinary GH excretion was measured using a highly sensitive sandwich enzyme immunoassay in 10 normal adults, 6 patients with hypopituitarism, 25 normal but short children who had normal plasma GH responses (peak plasma GH level, greater than 10 micrograms/L) to provocative tests, and 8 patients with acromegaly. The mean urinary GH values in the normal adults, patients with acromegaly, and patients with hypopituitarism were 13.8 +/- 4.0 (+/- SE) and 431.1 +/- 149.1 ng/g creatinine (Cr) (1.56 +/- 0.45 and 48.77 +/- 16.87 ng/mmol Cr) and undetectable, respectively; these mean values were significantly different from each other. In the normal but short children the urinary values ranged from undetectable to 55.8 ng/g Cr (6.31 ng/mmol Cr). All of the normal but short children and 4 patients with hypopituitarism participated in a 24-h endogenous GH secretion study. The urinary GH values correlated significantly with the mean 24-h plasma GH concentrations as an index of endogenous GH secretion (r = 0.81; P less than 0.001) and plasma somatomedin-C levels (r = 0.67; P less than 0.001), respectively. In 6 patients with acromegaly whose plasma GH levels were constant throughout a 4-h period, the urinary GH values also significantly correlated with the mean plasma GH levels (r = 0.95; P less than 0.01). These data indicate that urinary GH measurements reflect endogenous GH secretion and that measurement of urinary GH excretion is a useful, simple, and practical method for evaluating endogenous GH secretion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286672     DOI: 10.1210/jcem-66-6-1119

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.

Authors:  Neera Gupta; Robert H Lustig; Michael A Kohn; Marjorie McCracken; Eric Vittinghoff
Journal:  Inflamm Bowel Dis       Date:  2011-02-01       Impact factor: 5.325

2.  Urinary growth hormone excretion rates in normal and acromegalic man: a critical appraisal of its potential clinical utility.

Authors:  L M Winer; M A Shaw; G Baumann
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

3.  Plasma and urinary GH following a standardized exercise protocol to assess GH production in short children.

Authors:  A Sartorio; E Palmieri; V Vangeli; G Conte; M Narici; G Faglia
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

4.  Relationship between urinary and serum growth hormone and pubertal status.

Authors:  E C Crowne; W H Wallace; S M Shalet; G M Addison; D A Price
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

5.  Growth hormone and insulin-like growth factor-1 in blood and urine as response markers during treatment of acromegaly with octreotide: a double-blind placebo-controlled study.

Authors:  L Fredstorp; S Werner
Journal:  J Endocrinol Invest       Date:  1993-04       Impact factor: 4.256

6.  The height of the pituitary in preterm infants during the first 2 years of life: an MRI study.

Authors:  D Kiortsis; V Xydis; A G Drougia; P I Argyropoulou; S Andronikou; S C Efremidis; M I Argyropoulou
Journal:  Neuroradiology       Date:  2004-02-21       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.